Inflammatory bowel disease and pregnancy

被引：5

作者：

Maliszewska, Anna M. ^{[1
]}

Warska, Aleksandra ^{[1
]}

Cendrowski, Krzysztof ^{[1
]}

Sawicki, Wlodzimierz ^{[1
]}

机构：

[1] Med Univ Warsaw, Fac Med 2, Chair & Clin Obstet Gynecol & Oncol, 8 Kondratowicza St, PL-03242 Warsaw, Poland

来源：

GINEKOLOGIA POLSKA | 2017年 / 88卷 / 07期

关键词：

inflammatory bowel disease; pregnancy; lactation; CROHNS-DISEASE; RISK-FACTOR; WOMEN; POSTPARTUM; FERTILITY; CONSENSUS; DELIVERY; OUTCOMES; CHILDREN; COHORT;

D O I：

10.5603/GP.a2017.0074

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Inflammatory bowel disease (IBD) comprising Crohn's disease (CD), ulcerative colitis (UC), and IBD-unclassified (IBD-U) may appear at any age. As such, IBD commonly affects young patients in their reproductive age. Rate of voluntary childlessness among women with IBD far exceed that of the general population, as patients with IBD fear not only the effect of pregnancy on the course of inflammatory bowel disease, but also the increased risk of the offspring developing the disease, adverse pregnancy outcomes, the effect IBD treatment may have on the health and development of the infant or the risk of relapse during pregnancy and the influence of lactation on child development and disease course. This article aims at improving pre-conception counseling of patients with inflammatory bowel disease.

引用

页码：398 / 403

页数：6

共 36 条

[1] Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study [J].

Ban, L. ;

Tata, L. J. ;

Humes, D. J. ;

Fiaschi, L. ;

Card, T. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (07) :855-866

[2] Limited Risks of Major Congenital Anomalies in Children of Mothers With IBD and Effects of Medications [J].

Ban, Lu ;

Tata, Laila Jal ;

Fiaschi, Linda ;

Card, Timothy .

GASTROENTEROLOGY, 2014, 146 (01) :76-84

[3]

BRANDT LJ, 1995, AM J GASTROENTEROL, V90, P1918

[4]

Castiglione F, 1996, ITAL J GASTROENTEROL, V28, P199

[5] Early Pregnancy Azathioprine Use and Pregnancy Outcomes [J].

Cleary, Brian J. ;

Kallen, Bengt .

BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2009, 85 (07) :647-654

[6] Treating Inflammatory Bowel Disease in Pregnancy: The Issues We Face Today [J].

Damas, Oriana M. ;

Deshpande, Amar R. ;

Avalos, Danny J. ;

Abreu, Maria T. .

JOURNAL OF CROHNS & COLITIS, 2015, 9 (10) :928-936

[7] The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies [J].

de Lima-Karagiannis, Alison ;

Zelinkova-Detkova, Zuzana ;

van der Woude, Christien Janneke .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (09) :1305-1312

[8] Managing IBD Therapies in Pregnancy [J].

Jill K. J. Gaidos ;

Sunanda V. Kane .

Current Treatment Options in Gastroenterology, 2017, 15 (1) :71-83

[9] Pregnancy and delivery before and after real pouch-anal anastomosis for inflammatory bowel disease: Immediate and long-term consequences and outcomes [J].

Hahnloser, D ;

Pemberton, JH ;

Wolff, BG ;

Larson, D ;

Harrington, J ;

Farouk, R ;

Dozois, RR .

DISEASES OF THE COLON & RECTUM, 2004, 47 (07) :1127-1135

[10]

Hashash Jana G, 2015, Gastroenterol Hepatol (N Y), V11, P96

← 1 2 3 4 →